Aids Dementia Complex
📧 Sign up to get email alerts when something new happens for Aids Dementia Complex.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection [Phase 3]
A multicenter Phase 3 double-blind trial evaluating azidothymidine (AZT) for AIDS dementia complex and CNS HIV infection has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex [Phase 2]
Phase 2 trial comparing ddI and zidovudine in AIDS dementia complex and HIV infection; completed.
-
CLINICAL_TRIALS trial_result · 2021-10-29Clinical Trial Update: An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts [Phase 3]
Phase 3 trial evaluating zidovudine (AZT) for AIDS Dementia Complex in AIDS patients; study completed.
-
CLINICAL_TRIALS trial_result · 2021-08-30Clinical Trial Update: Maraviroc and NeuroAIDS Pathogenesis [Phase 2, Phase 3]
Phase 2/3 clinical trial update on maraviroc for AIDS dementia complex (neuroAIDS pathogenesis).
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: Effect of Cenicriviroc on HIV Neurocognitive Impairment [Phase 2]
Phase 2 trial evaluating cenicriviroc for HIV-associated neurocognitive impairment has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS [Phase 2]
Phase 2 clinical trial update on ferumoxytol-enhanced imaging and mapping in neuroAIDS; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2011-05-04Clinical Trial Update: A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex [Phase 3]
A Phase 3 clinical trial evaluating stavudine (d4T) for AIDS dementia complex has completed.